Agents for treatment of brain ischemia

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514273, 514275, 544295, 544320, 544321, 544330, 544331, 544332, A61K 31495, C07D40304

Patent

active

049944606

ABSTRACT:
A series of 5-halopyrimidin-2-ylpiperazinylalkyl derivatives having useful anti-ischemic properties for treatment and prevention of dirorders resulting from brain and/or spinal cord anoxia.

REFERENCES:
patent: 2973360 (1961-02-01), Janssen et al.
patent: 3299067 (1967-01-01), Regnier et al.
patent: 3808210 (1974-04-01), Regnier et al.
patent: 4316899 (1982-02-01), Markwell
patent: 4605655 (1986-08-01), Yevich et al.
patent: 4711899 (1987-12-01), Gaudillier
patent: 4857644 (1989-08-01), Abou-Gharbia
Regnier et al, "Chemical Abstracts", vol. 70, 1969, col. 11717k.
Yevich, et al., "Chemical Abstracts", vol. 104, 1986, col. 109686v.
Gotti, et al., JPET, 247/3, pp. 1211-1221; (1988) (4/9).
Wauquier, et al., in "Drug Development Research", 8, pp. 373-380; (4/14).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Agents for treatment of brain ischemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agents for treatment of brain ischemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents for treatment of brain ischemia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1143827

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.